A German company that provides products and services that accelerate drug development and manufacturing is set to acquire the ...
Pharmaceutical Technology on MSN
Merck KGaA to buy Bio-Techne for $11.3bn in life science footprint expansion
The deal is Merck’s largest since 2015, when it spent $17bn on acquiring Sigma-Aldrich, also a life sciences specialist.
Join the Boston Business Journal for our 6th annual program on women in life sciences. Don't miss this jam-packed afternoon ...
Axtria Inc., a global leader in AI-first data & analytics solutions and platforms for the life sciences industry, hosted ...
Replimune’s application is the latest example of changing attitudes at the FDA. Elsewhere, Revolution Medicines outlined more ...
Merck KGaA, Darmstadt, Germany, a leading science and technology company, and Bio-Techne Corporation, a Minneapolis-based ...
ASP Isotopes and ENDRA stock plunge as Noble Africa merger and $50M private placement reshape ownership and leadership.
M&A: Life Science Connect Buys Organizer of CDMO Live to Build Biopharma Outsourcing Events Division
Companies say the acquisition will accelerate growth with investment and an AI-enabled platform focused on curated ...
IQVIA controls one of the world's largest databases of healthcare information that's closely integrated the clinical research ...
OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences ...
Hatch BioFund, an early-stage life sciences venture capital firm headquartered at the Pennsylvania Biotechnology Center in Doylestown, PA ("Hatch"), today announced an investment in Optimeos Life ...
Merck KGaA has agreed to acquire biotech firm Bio-Techne Corp for $73 per share in cash, the German science and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results